Online Only Articles

Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis

Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
Vol. 105 No. 5 (2020): May, 2020 https://doi.org/10.3324/haematol.2019.222471